FGEN 12.24 ▼ -1.13% Live Trading Data - Stocknear

FibroGen Inc.

NASDAQ: FGEN · Real-Time Price · USD
12.24
-0.14 (-1.13%)
At close: Sep 25, 2025, 3:59 PM
12.24
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-1.13%
Bid 11.53
Market Cap 49.52M
Revenue (ttm) -72.84M
Net Income (ttm) -2.07M
EPS (ttm) -21.61
PE Ratio (ttm) -0.57
Forward PE -0.79
Analyst Buy
Dividends n/a
Ask 12.59
Volume 30,437
Avg. Volume (20D) 51,250
Open 12.33
Previous Close 12.38
Day's Range 12.06 - 12.58
52-Week Range 4.50 - 21.95
Beta 0.77
Ex-Dividend Date n/a

About FGEN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FGEN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for FGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
FibroGen Inc. is scheduled to release its earnings on Nov 11, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+19.07%
FibroGen shares are trading higher after the compa... Unlock content with Pro Subscription
1 month ago
+10.51%
FibroGen shares are trading higher after the company reported better-than-expected Q2 EPS results. Also, the company announced it will sell its China business to AstraZeneca for $210 million.